Bright night light exposure increases mortality risk, while daylight reduces it

Study reveals that brighter night light exposure and circadian rhythm disruption significantly increase the risk of mortality, particularly from cardiometabolic diseases, while brighter daytime light lowers these risks.

Orion sees highest filings and grants during May in Q2 2024

Orion has been focused on protecting inventions in United States(US) with eight publications in Q2 2024 The United States(US) Patent Office dominates the patent filings

July 21, 2024

ActiGraph and Hyfe Launch AI-Powered Cough Detection for Clinical Trials

What You Should Know: – ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in

January 29, 2025

SGLT2 Inhibitor Carry-Over Benefits Last How Long?

SAN DIEGO — Benefits with empagliflozin (Jardiance) for cardiovascular and renal health linger for about a year after discontinuation, as off-drug follow-up from the EMPA-KIDNEY

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.